Exhibits 16.1
August 16, 2024
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by Citius Oncology, Inc. (formerly known as TenX Keane Acquisition) under Item 4.01 of its Form 8-K dated August 12, 2024. We agree with the statements concerning our Firm under Item 4.01 in such Form 8-K; we are not in a position to agree or disagree with other statements of Citius Oncology, Inc. (formerly known as TenX Keane Acquisition) contained therein.
Very truly yours,
/s/ Marcum llp
Marcum llp